IPO Monitor
Subscribe Login Login About Us Contact Us Help
Recent Filings - Secondary Offerings
Date Company Location Amount
2017-05-24 Costamare Inc. Athens, GREECE N/A
 An international owner of containerships, chartering our vessels to many of the world’s largest liner companies.
2017-05-24 Ecoark Holdings, Inc. Rogers, AR $10.0 mil.
 Engages in deployment of business solutions and products to the retail, agriculture, food service, commercial real estate and ar
2017-05-23 Syndax Pharmaceuticals Inc Waltham, MA $50.0 mil.
 A late-stage biopharmaceutical company
2017-05-23 Albireo Pharma, Inc. Boston, MA $45.1 mil.
 A specialty pharmaceutical company.
2017-05-23 Alnylam Pharmaceuticals, Inc. Cambridge, MA N/A
 Develops therapeutics based on a recently discovered biological pathway known as RNA interference.
2017-05-23 Rapid7 Inc Boston, MA $50.0 mil.
 A leading provider of security data and analytics solutions
2017-05-23 Achaogen Inc South San Francisco, CA N/A
 A clinical-stage biopharmaceutical company
2017-05-23 Scorpio Tankers Inc. MONACO $200.0 mil.
 Provides seaborne transportation of crude oil and other petroleum products worldwide.
2017-05-22 GlycoMimetics, Inc. Gaithersburg, MD $80.5 mil.
 A clinical stage biotechnology company
2017-05-22 Berkshire Hills Bancorp Inc. Pittsfield, MA $160.0 mil.
 The largest banking institution based in Western Massachusetts.
2017-05-22 Applied DNA Sciences, Inc. Stony Brook, NY $25.0 mil.
 Provides botantical-DNA based security and authentication solutions
2017-05-22 Entegra Financial Corp. Franklin, NC $50.0 mil.
 A stock savings bank
2017-05-19 BioCardia, Inc. San Carlos, CA $50.0 mil.
 A clinical-stage regenerative medicine company
2017-05-19 Independence Realty Trust, Inc. Philadelphia, PA $1,000.0 mil.
 Owns well-located apartment properties in geographic submarkets
2017-05-19 County Bancorp, Inc. Manitowoc, WI $75.0 mil.
 A registered bank holding company
2017-05-19 Bridgeline Digital, Inc. Burlington, MA $10.0 mil.
 Is a developer of Web software tools and Web applications.
2017-05-19 Galectin Therapeutics Inc. Newton, MA $100.0 mil.
 A development-stage company engaged in drug development to create new therapies for cancer and fibrotic disease.
2017-05-19 Global Net Lease, Inc. New York, NY $175.0 mil.
 Qualified as a REIT for U.S. federal income tax purposes
2017-05-18 Halozyme Therapeutics Inc. San Diego, CA $125.0 mil.
 A biopharmaceutical company.
2017-05-17 Regency Centers Corp. Jacksonville, FL $500.0 mil.
 A real estate investment trust or "REIT".
More >>

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2017 IPO Monitor. All rights reserved